__timestamp | AbbVie Inc. | Travere Therapeutics, Inc. |
---|---|---|
Wednesday, January 1, 2014 | 19960000000 | 28203205 |
Thursday, January 1, 2015 | 22859000000 | 99892000 |
Friday, January 1, 2016 | 25638000000 | 133591000 |
Sunday, January 1, 2017 | 28216000000 | 154937000 |
Monday, January 1, 2018 | 32753000000 | 164246000 |
Tuesday, January 1, 2019 | 33266000000 | 175338000 |
Wednesday, January 1, 2020 | 45804000000 | 198321000 |
Friday, January 1, 2021 | 56197000000 | 227490000 |
Saturday, January 1, 2022 | 58054000000 | 212018000 |
Sunday, January 1, 2023 | 54318000000 | 145238000 |
Monday, January 1, 2024 | 56334000000 |
Infusing magic into the data realm
In the ever-evolving landscape of the pharmaceutical industry, revenue growth is a key indicator of a company's success and market position. Over the past decade, AbbVie Inc. has demonstrated a remarkable revenue trajectory, showcasing a growth of approximately 172% from 2014 to 2023. In contrast, Travere Therapeutics, Inc., while showing consistent growth, has maintained a more modest revenue increase of around 415% over the same period.
AbbVie's revenue peaked in 2022, reaching a staggering $58 billion, before slightly declining in 2023. Meanwhile, Travere's revenue, though significantly smaller, reached its highest in 2021 at $227 million. This comparison highlights the vast scale difference between the two companies, with AbbVie's revenue being over 250 times that of Travere's in 2023. Such insights underscore the diverse strategies and market positions within the pharmaceutical sector.
Eli Lilly and Company vs AbbVie Inc.: Annual Revenue Growth Compared
AbbVie Inc. vs Regeneron Pharmaceuticals, Inc.: Annual Revenue Growth Compared
Comparing Revenue Performance: AbbVie Inc. or GSK plc?
Revenue Insights: AbbVie Inc. and Perrigo Company plc Performance Compared
AbbVie Inc. vs Galapagos NV: Examining Key Revenue Metrics
Who Generates More Revenue? Regeneron Pharmaceuticals, Inc. or Travere Therapeutics, Inc.
Genmab A/S or Travere Therapeutics, Inc.: Who Leads in Yearly Revenue?
Revenue Insights: Cytokinetics, Incorporated and Travere Therapeutics, Inc. Performance Compared
Revenue Showdown: TG Therapeutics, Inc. vs Travere Therapeutics, Inc.
Who Generates More Revenue? Dynavax Technologies Corporation or Travere Therapeutics, Inc.
Who Generates More Revenue? Travere Therapeutics, Inc. or Celldex Therapeutics, Inc.
Travere Therapeutics, Inc. and Viridian Therapeutics, Inc.: A Comprehensive Revenue Analysis